No black box warning on record for Poteligeo
As of the latest FDA labeling reviewed, Poteligeo (MOGAMULIZUMAB-KPKC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Poteligeo medicine page for the complete safety profile.